This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

An ink for solvent-cast 3D printing is provided. The ink comprises a solution or gel of a polymer in a volatile solvent, and carbon nanotubes dispersed in the solution or gel. In the ink, the carbon nanotubes are present in a carbon nanotubes:polymer weight ratio between about 20:80 and about 40:60, and the polymer and carbon nanotubes total concentration is between about 20 and about 35 wt %, based on the total weight of the ink. There is also provided a 3D printer ink cartridge comprising the ink; a method of manufacturing the ink; a method of manufacturing a solvent-cast 3D printed material using the ink, a solvent-cast 3D printed material as well as uses thereof.

An ink for solvent-cast 3D printing is provided. The ink comprises a solution or gel of a polymer in a volatile solvent, and carbon nanotubes dispersed in the solution or gel. In the ink, the carbon nanotubes are present in a carbon nanotubes:polymer weight ratio between about 20:80 and about 40:60, and the polymer and carbon nanotubes total concentration is between about 20 and about 35 wt %, based on the total weight of the ink. There is also provided a 3D printer ink cartridge comprising the ink; a method of manufacturing the ink; a method of manufacturing a solvent-cast 3D printed material using the ink, a solvent-cast 3D printed material as well as uses thereof.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

An ink for solvent-cast 3D printing is provided. The ink comprises a solution or gel of a polymer in a volatile solvent, and carbon nanotubes dispersed in the solution or gel. In the ink, the carbon nanotubes are present in a carbon nanotubes:polymer weight ratio between about 20:80 and about 40:60, and the polymer and carbon nanotubes total concentration is between about 20 and about 35 wt %, based on the total weight of the ink. There is also provided a 3D printer ink cartridge comprising the ink; a method of manufacturing the ink; a method of manufacturing a solvent-cast 3D printed material using the ink, a solvent-cast 3D printed material as well as uses thereof.